It is a kind of soft tissue sarcoma that takes place
in mesenchymal cells;these are undeveloped cells in turn forms as a muscle. A
tumor may be cancerous or benign. All cancerous tumors are malignant, sense it
can spread to other parts of the body, while benign tumor is less prone to
spreading. Generally
disease develops in a type of muscle called striated muscle. It can transpire
anywhere in the body and most of the Rhabdomyosarcoma cases are seen at 39% in
Head and Neck region, 24% in parameningeal sites, 8% in eye socket and29% urinary or reproductive organs and 15% Arms or legs. Advanced
studies suggests the use of Immunotherapy/biologic therapies, thatcan enhance
the body's natural defenses to fight against the Rhabdomyosarcoma, often it uses
resources made either by the body or in a laboratory to reinforce, aim, or
repair immune system role.
Two types of rhabdomyosarcoma are embryonal and
alveolar.Embryonal rhabdomyosarcoma is seen most frequently in children under
age five. Embryonal rhabdomyosarcoma also affects the testicles, head and neck,
prostate, vegina, or bladder.Alveolar rhabdomyosarcoma occurs in all age groups
and often affects the large muscles of the trunks, legs, and arms.
As per the stats projected by United States, about
350 people are getting diagnosed every year. The disease is highly associated
within the children of age 10. Overall five year survival rate claims around
64% for the children within the age group of 14 and it varies as the age
prolongs.Children with rare inherited conditions have a higher risk of
developing the disease such as Li-Fraumeni syndrome, Beckwith – Wiedemann
syndrome, Neurofibromatosis, Costello syndrome and Cardio-facio-cutaneous
syndrome.
Disease
can be detectedby offering subsequent tests such asComputed tomography (CT /CAT)
scan, Magnetic resonance imaging (MRI), Biopsy and Lumbar puncture (spinal
tap). Initially treatment is preceded by surgery and after then the physician
plan for going to chemotherapy or radio therapy. Use of traditional methods
will always leads to adverse side effects to the patients. So, research is
ongoing to overcome this draw back and looking ahead for redesigning the
medical treatments that launches a better treatment conditions.
Under
such circumstances their arise a launch of biological therapies for treating
bladder cancer are Monoclonal antibodies, Cytokine therapy, Vaccine therapy,
Adoptive T-cell therapy, Oncolytic virus therapy, Gene therapy, DNA
oligonucleotide therapy and RNA oligonucleotide therapy. Introduction of such
drugs will be a miracle in future by promoting better treatment options, higher
curing capacity and successfully drives the patient with less prone to side
effects. Approved drugs by FDA for curing Rhabdomyosarcoma are Cosmegen,
Dactinomycin, Vincasar PFS and Vincristine Sulfate.
Global
Allied Pharmaceuticals (GAP) has a professional team for Cancer related
services. Our company is functioning to provide service at your door steps.
Be
in touch with Global Allied Pharmaceuticals to explore more on Cancer related
assistance. We are privileged to serve you. Kindly visit http://www.gapsos.com/for
further queries.
No comments:
Post a Comment